CoStone Capital

CoStone Capital is a prominent Chinese investment firm headquartered in Shenzhen, specializing in venture capital and private equity investments. Established in 2001, the firm has over 20 years of experience in investment management, managing approximately 85 billion RMB in assets across various investment types, including angel investments, venture capital, private equity, mergers and acquisitions, and private placements. CoStone Capital operates nine offices across China and in Silicon Valley, providing comprehensive asset management services to investors and portfolio companies.

The firm's investment strategy focuses on high-growth industries aligned with China's economic development, emphasizing sectors such as technology, healthcare, and life sciences. CoStone Capital adopts a concentrated investment approach, limiting the number of investments to achieve high returns. The firm places significant importance on a company's core technologies and the capabilities of its founding team, ensuring they can effectively serve customers. CoStone Capital has developed a dedicated technology investment team to better understand the core technologies of its portfolio companies.

CoStone Capital has a track record of successful investments, including notable companies like SenseTime, OmniVision Technologies, Mindray, MGI, 4Paradigm, CloudWalk Technology, and Royole. The firm also held a 15% stake in Morgan Stanley's China joint venture, Morgan Stanley Huaxin Funds, which it sold to Morgan Stanley in 2021. CoStone Capital's investment philosophy centers on being the organizer of the industry chain, empowering partners, and investing in technology to construct entrepreneurial dedication, aiming to present generous returns for trust and contribute to national innovation power.